EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS

The article presents a case report of recurrent clinical course of polyarticular type of juvenile rheumatoid arthritis, which is characterized with rapid development of disability, low quality of life, high index of functional insufficiency, torpid flow. The disease developed with intolerance to met...

Full description

Saved in:
Bibliographic Details
Main Authors: T.M. Bzarova, E.I. Alexeeva, S.I. Valieva, A.M. Chomakhidze, K.B. Isaeva, A.O. Lisitsyn, R.V. Denisova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-07-01
Series:Вопросы современной педиатрии
Online Access:https://vsp.spr-journal.ru/jour/article/view/935
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849242364319629312
author T.M. Bzarova
E.I. Alexeeva
S.I. Valieva
A.M. Chomakhidze
K.B. Isaeva
A.O. Lisitsyn
R.V. Denisova
author_facet T.M. Bzarova
E.I. Alexeeva
S.I. Valieva
A.M. Chomakhidze
K.B. Isaeva
A.O. Lisitsyn
R.V. Denisova
author_sort T.M. Bzarova
collection DOAJ
description The article presents a case report of recurrent clinical course of polyarticular type of juvenile rheumatoid arthritis, which is characterized with rapid development of disability, low quality of life, high index of functional insufficiency, torpid flow. The disease developed with intolerance to metotrexate and presence of contra-indications to blockers of tumor necrotizing factor _. Authors describe successful treatment with inhibitor of T-lymphocytes co-stimulation abatacept. The dose of drug was 10 mg/kg of body weight during 24 weeks. In two weeks after the beginning of treatment pain and exudative lesions in joints were lessened, joint range of motions significantly increased. The quality of life of patient and her family increased in 4 weeks of treatment with abatacept. The drug induced clinical and laboratory remission in 24 weeks.Key words: children, juvenile rheumatoid arthritis, abatacept, treatment.(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(4):147-154)
format Article
id doaj-art-478f8f2e78b941ecb9eea69593cd591d
institution Kabale University
issn 1682-5527
1682-5535
language English
publishDate 2010-07-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj-art-478f8f2e78b941ecb9eea69593cd591d2025-08-20T03:59:52Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352010-07-0194147154936EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIST.M. Bzarova0E.I. Alexeeva1S.I. Valieva2A.M. Chomakhidze3K.B. Isaeva4A.O. Lisitsyn5R.V. Denisova6Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowThe article presents a case report of recurrent clinical course of polyarticular type of juvenile rheumatoid arthritis, which is characterized with rapid development of disability, low quality of life, high index of functional insufficiency, torpid flow. The disease developed with intolerance to metotrexate and presence of contra-indications to blockers of tumor necrotizing factor _. Authors describe successful treatment with inhibitor of T-lymphocytes co-stimulation abatacept. The dose of drug was 10 mg/kg of body weight during 24 weeks. In two weeks after the beginning of treatment pain and exudative lesions in joints were lessened, joint range of motions significantly increased. The quality of life of patient and her family increased in 4 weeks of treatment with abatacept. The drug induced clinical and laboratory remission in 24 weeks.Key words: children, juvenile rheumatoid arthritis, abatacept, treatment.(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(4):147-154)https://vsp.spr-journal.ru/jour/article/view/935
spellingShingle T.M. Bzarova
E.I. Alexeeva
S.I. Valieva
A.M. Chomakhidze
K.B. Isaeva
A.O. Lisitsyn
R.V. Denisova
EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
Вопросы современной педиатрии
title EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
title_full EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
title_fullStr EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
title_full_unstemmed EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
title_short EXPERIENCE OF TREATMENT WITH INHIBITOR OF T-LYMPHOCYTES CO-STIMULATION ABATACEPT IN PATIENT WITH POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
title_sort experience of treatment with inhibitor of t lymphocytes co stimulation abatacept in patient with polyarticular type of juvenile rheumatoid arthritis
url https://vsp.spr-journal.ru/jour/article/view/935
work_keys_str_mv AT tmbzarova experienceoftreatmentwithinhibitoroftlymphocytescostimulationabataceptinpatientwithpolyarticulartypeofjuvenilerheumatoidarthritis
AT eialexeeva experienceoftreatmentwithinhibitoroftlymphocytescostimulationabataceptinpatientwithpolyarticulartypeofjuvenilerheumatoidarthritis
AT sivalieva experienceoftreatmentwithinhibitoroftlymphocytescostimulationabataceptinpatientwithpolyarticulartypeofjuvenilerheumatoidarthritis
AT amchomakhidze experienceoftreatmentwithinhibitoroftlymphocytescostimulationabataceptinpatientwithpolyarticulartypeofjuvenilerheumatoidarthritis
AT kbisaeva experienceoftreatmentwithinhibitoroftlymphocytescostimulationabataceptinpatientwithpolyarticulartypeofjuvenilerheumatoidarthritis
AT aolisitsyn experienceoftreatmentwithinhibitoroftlymphocytescostimulationabataceptinpatientwithpolyarticulartypeofjuvenilerheumatoidarthritis
AT rvdenisova experienceoftreatmentwithinhibitoroftlymphocytescostimulationabataceptinpatientwithpolyarticulartypeofjuvenilerheumatoidarthritis